29 July 2022
The 600 Group PLC
("600 Group" or "the Group")
Exercise of Options and Total Voting Rights
600 Group plc, the Industrial Laser Systems Business (AIM: SIXH), announces that following the exercise of share options under the 600 Group PLC 2011 Deferred Share Plan by an employee of the Group, the Group has made application for 40,000 new ordinary shares of 1p each in the Company ("New Ordinary Shares") to be admitted to trading on AIM ("Admission").
The New Ordinary Shares shall rank pari passu with the existing ordinary shares in issue and Admission is expected to become effective at 8.00am on or around 4 August 2022.
For the purpose of the Disclosure Guidance and Transparency Rules of the FCA, the issued share capital of the Company on Admission will comprise 117,963,341 ordinary shares, none of which are held in treasury. Therefore, the total number of ordinary shares with voting rights in the Group following Admission will be 117,963,341.
The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the FCA's Disclosure Guidance and Transparency Rules.
ENDS
Enquiries:
The 600 Group PLC Paul Dupee, Executive Chairman |
Tel: +1-407-818-1123 |
Instinctif Partners Tim McCall |
Tel: 0207 457 2020 |
Cenkos Securities plc (Nominated Adviser and Broker) Ben Jeynes / Max Gould (Corporate Finance) Alex Pollen / Henry Nicol (Sales) |
Tel: 020 7397 8900 |
About The 600 Group PLC
The 600 Group PLC is focussed on the delivery of Industrial laser systems which cover laser marking and processing including cutting, drilling, ablation and a host of other niche applications in the marking and micro machining sectors. They require no consumables and can operate on a continuous high speed basis and can be integrated into customers' production lines. The businesses have their own technology and proprietary software. Customer applications are diverse and range from aerospace to medical and pharmaceuticals. The requirement for increased product and component traceability is one of the market drivers.
More information on the Group can be viewed at: www.600group.com